Source: Myeloma – Hematology Advisor
Elranatamab is a B-cell maturation antigen (BCMA) CD3-targeted bispecific antibody.
Read More
by | Feb 27, 2023 | Myeloma News | 0 comments
Source: Myeloma – Hematology Advisor
Elranatamab is a B-cell maturation antigen (BCMA) CD3-targeted bispecific antibody.
Read More